FBXO5 and breast cancer: Similarly, existing researches also demonstrated that FBXO5 upregulation was critically correlated to the poor prognosis of esophageal squamous cell carcinoma (10), hepatocellular carcinoma (12), squamous cell lung carcinoma (23), and breast cancer (11, 24).